Search Results for agency_names:"Health and Human Services Department"

The Eunice Kennedy Shriver National Institute of Child Health and Human Development has announced a closed meeting scheduled for May 6, 2025. The meeting will focus on reviewing and evaluating grant applications related to small businesses in rehabilitation and bioengineering. It will be conducted virtually to protect confidential information and personal privacy. Interested parties can contact Magnus A. Azuine, Ph.D., for more details.

The Office of Refugee Resettlement (ORR) under the U.S. Department of Health and Human Services is seeking public comments on its request to extend, for one more year, the use of Form ORR-1 for the Cash and Medical Assistance Program. This form helps estimate the financial needs for providing assistance to refugees and certain other eligible groups. Feedback is encouraged within 30 days of the notice's publication, as the Office of Management and Budget (OMB) will decide about the information collection within 30 to 60 days. The program is vital for states to receive reimbursement for services offered to eligible individuals upon their arrival in the United States.

The National Advisory Council on Alcohol Abuse and Alcoholism has announced a change to its previously scheduled meeting times. Initially set for April 17, 2025, from 11:00 a.m. to 12:30 p.m., the meeting will now occur from 12:30 p.m. to 2:00 p.m. The meeting will take place at the National Institutes of Health in Bethesda, Maryland, and is closed to the public. This adjustment was published in the Federal Register on March 21, 2025.

The Office of Minority Health announced the cancellation of a meeting for the Advisory Committee on Minority Health that was scheduled for January 7, 2025. This cancellation was initially announced in the Federal Register on December 9, 2024. For more information, individuals can contact Violet Woo, the Designated Federal Officer, via telephone or email.

The Indian Health Service (IHS), part of the Department of Health and Human Services, has announced a reorganization of its headquarters, specifically focusing on the Office of Information Technology (OIT) and the Office of Management Services (OMS). The reorganization aims to update structures, improve efficiency, and align with current technology and administration requirements. The new structure, approved by the Secretary of Health and Human Services, will streamline operations within these offices to better serve the healthcare needs of Indian communities. This change involves various functions like cybersecurity, records management, emergency preparedness, and asset management, enhancing the IHS's ability to support healthcare services.

The National Library of Medicine is holding a meeting of its Board of Regents on May 13, 2025. Part of the meeting will be open to the public from 10:00 a.m. to 4:00 p.m. and will focus on program discussions. This meeting will be conducted virtually and can be accessed via the NIH Videocast website. Additionally, a closed session from 4:00 p.m. to 4:30 p.m. will address grant applications, which includes confidential information. Members of the public can submit comments up to 15 days before the meeting.

The National Institute of Allergy and Infectious Diseases (NIAID) is offering royalty-free access to a specially developed starting material, known as "MVA clone-1," for creating and commercializing a vaccine against mpox. This initiative aims to improve vaccine access, especially in underserved regions, and respond to a 2024 public health emergency called by the World Health Organization due to a significant outbreak in the Democratic Republic of the Congo. Interested parties with solid plans to develop and distribute the vaccine in high-need areas can collaborate with NIAID. The material shows promise as it is similar to an already approved vaccine and has been shown to protect against mpox in both normal and at-risk populations.

The Office of Research Integrity (ORI) found Liping Zhang, Ph.D., a former professor at Baylor College of Medicine, guilty of research misconduct. The violations involved falsifying images in unpublished manuscripts and grant applications funded by government health agencies like the NIH. Zhang did not contest the findings, which led to a two-year ban from participating in certain federal transactions and advisory roles. This decision took effect in early 2025 to safeguard the integrity of federal research endeavors.

The Food and Drug Administration (FDA) is withdrawing the approval of 27 abbreviated new drug applications because the companies that made these drugs told the FDA that they are no longer selling them. The withdrawal means these drugs will no longer have permission to be sold in the market. This action will take effect on February 16, 2021, but any remaining drug inventory that is still compliant with regulations can be used up until it runs out or expires.

The National Institute of Allergy and Infectious Diseases is considering granting an exclusive patent license to Cambridge Enterprise Limited, part of the University of Cambridge, to develop and market certain inventions. These inventions involve conductive polymer coated electrodes used for single-cell electroporation in clinical settings. This license would help consolidate patent rights and speed up the commercial development of the invention, which is in line with promoting innovation according to U.S. law. Public comments or applications for this license must be submitted by May 2, 2025, and will be considered by the institute.